Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma

Background Radiation therapy (RT) is increasingly utilized in conjunction with surgery for the treatment of retroperitoneal soft tissue sarcomas (RPS). Despite multiple theoretical advantages of RT, its role in the surgical management of this disease remains ill defined. Methods Patients undergoing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of surgical oncology 2015-09, Vol.112 (4), p.352-358
Hauptverfasser: Lane, Whitney O., Cramer, Christina K., Nussbaum, Daniel P., Speicher, Paul J., Gulack, Brian C., Czito, Brian G., Kirsch, David G., Tyler, Douglas S., Blazer III, Dan G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 358
container_issue 4
container_start_page 352
container_title Journal of surgical oncology
container_volume 112
creator Lane, Whitney O.
Cramer, Christina K.
Nussbaum, Daniel P.
Speicher, Paul J.
Gulack, Brian C.
Czito, Brian G.
Kirsch, David G.
Tyler, Douglas S.
Blazer III, Dan G.
description Background Radiation therapy (RT) is increasingly utilized in conjunction with surgery for the treatment of retroperitoneal soft tissue sarcomas (RPS). Despite multiple theoretical advantages of RT, its role in the surgical management of this disease remains ill defined. Methods Patients undergoing surgery for RPS from 1990 to 2011 were identified. Patients were classified as having primary or recurrent disease, and then further stratified by the use of perioperative RT. Primary outcomes, including overall survival (OS) and recurrence‐free survival (RFS), were estimated using the Kaplan‐Meier method with comparisons based on the log rank test. Cox‐proportional hazards modeling was used to estimate the independent effect of RT on survival. Results Ninety‐four patients met final inclusion criteria. After adjusting for confounding variables, perioperative RT remained independently associated with a reduced risk of recurrence (HR 0.34, P 
doi_str_mv 10.1002/jso.23996
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1716943109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1716943109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4616-578a21e4089bd3cf8ff194e57d200d9597505ef750688bb7cca533de9515e53f3</originalsourceid><addsrcrecordid>eNp1kTlv3DAQhQkjgb1xUvgPBATS2IVsHqJElsb6hrEucgFuCC41SriRxDVJOdl_H-5hFwHSDAec7z1g3iB0RMkpJYSdLaI_ZVypag9NKFFVoYiSb9Akz1hR1oocoHcxLgghmSn30QGrGJdMsgl6Ph9Mt4ouYt_iJQTnczHJPQMOpnG58wNOP_PfcoXdpsVxDD-cNR1OAUzqYUgbcXC9CStshgYHsGMI60GAFNaWLvkBsiSaYH1v3qO3rekifNi9h-jr1eWX6U1x_3B9Oz2_L2xZ0aoQtTSMQkmkmjfctrJtqSpB1A0jpFFC1YIIaHOtpJzPa2uN4LwBJagAwVt-iI63vsvgn0aISfcuWug6M4Afo6Y1rVTJc2gZ_fQPuvBjyOlsKKE4yZFl6mRL2eBjDNDq3d6aEr0-hs7H0JtjZPbjznGc99C8ki_pZ-BsC_x2Haz-76TvPj-8WBZbhYsJ_rwqTPilq5rXQn-fXetSzh7vLmZEf-N_AcLqpHM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1715930382</pqid></control><display><type>article</type><title>Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Lane, Whitney O. ; Cramer, Christina K. ; Nussbaum, Daniel P. ; Speicher, Paul J. ; Gulack, Brian C. ; Czito, Brian G. ; Kirsch, David G. ; Tyler, Douglas S. ; Blazer III, Dan G.</creator><creatorcontrib>Lane, Whitney O. ; Cramer, Christina K. ; Nussbaum, Daniel P. ; Speicher, Paul J. ; Gulack, Brian C. ; Czito, Brian G. ; Kirsch, David G. ; Tyler, Douglas S. ; Blazer III, Dan G.</creatorcontrib><description>Background Radiation therapy (RT) is increasingly utilized in conjunction with surgery for the treatment of retroperitoneal soft tissue sarcomas (RPS). Despite multiple theoretical advantages of RT, its role in the surgical management of this disease remains ill defined. Methods Patients undergoing surgery for RPS from 1990 to 2011 were identified. Patients were classified as having primary or recurrent disease, and then further stratified by the use of perioperative RT. Primary outcomes, including overall survival (OS) and recurrence‐free survival (RFS), were estimated using the Kaplan‐Meier method with comparisons based on the log rank test. Cox‐proportional hazards modeling was used to estimate the independent effect of RT on survival. Results Ninety‐four patients met final inclusion criteria. After adjusting for confounding variables, perioperative RT remained independently associated with a reduced risk of recurrence (HR 0.34, P &lt; 0.01) and death (HR 0.30, P = 0.02). Conclusions In this retrospective series, perioperative RT is an independent predictor of improved OS and RFS. These results provide additional support for the use of RT in the multimodality treatment of retroperitoneal sarcoma. J. Surg. Oncol. 2015; 112:352–358. © 2015 Wiley Periodicals, Inc.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.23996</identifier><identifier>PMID: 26238282</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - radiotherapy ; Neoplasm Recurrence, Local - surgery ; Perioperative Care ; Prognosis ; radiotherapy ; Radiotherapy, Adjuvant ; Retroperitoneal Neoplasms - mortality ; Retroperitoneal Neoplasms - pathology ; Retroperitoneal Neoplasms - radiotherapy ; Retroperitoneal Neoplasms - surgery ; retroperitonealsarcoma ; Retrospective Studies ; Sarcoma - mortality ; Sarcoma - pathology ; Sarcoma - radiotherapy ; Sarcoma - surgery ; surgery ; survival analysis ; Survival Rate</subject><ispartof>Journal of surgical oncology, 2015-09, Vol.112 (4), p.352-358</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4616-578a21e4089bd3cf8ff194e57d200d9597505ef750688bb7cca533de9515e53f3</citedby><cites>FETCH-LOGICAL-c4616-578a21e4089bd3cf8ff194e57d200d9597505ef750688bb7cca533de9515e53f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjso.23996$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjso.23996$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26238282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lane, Whitney O.</creatorcontrib><creatorcontrib>Cramer, Christina K.</creatorcontrib><creatorcontrib>Nussbaum, Daniel P.</creatorcontrib><creatorcontrib>Speicher, Paul J.</creatorcontrib><creatorcontrib>Gulack, Brian C.</creatorcontrib><creatorcontrib>Czito, Brian G.</creatorcontrib><creatorcontrib>Kirsch, David G.</creatorcontrib><creatorcontrib>Tyler, Douglas S.</creatorcontrib><creatorcontrib>Blazer III, Dan G.</creatorcontrib><title>Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma</title><title>Journal of surgical oncology</title><addtitle>J. Surg. Oncol</addtitle><description>Background Radiation therapy (RT) is increasingly utilized in conjunction with surgery for the treatment of retroperitoneal soft tissue sarcomas (RPS). Despite multiple theoretical advantages of RT, its role in the surgical management of this disease remains ill defined. Methods Patients undergoing surgery for RPS from 1990 to 2011 were identified. Patients were classified as having primary or recurrent disease, and then further stratified by the use of perioperative RT. Primary outcomes, including overall survival (OS) and recurrence‐free survival (RFS), were estimated using the Kaplan‐Meier method with comparisons based on the log rank test. Cox‐proportional hazards modeling was used to estimate the independent effect of RT on survival. Results Ninety‐four patients met final inclusion criteria. After adjusting for confounding variables, perioperative RT remained independently associated with a reduced risk of recurrence (HR 0.34, P &lt; 0.01) and death (HR 0.30, P = 0.02). Conclusions In this retrospective series, perioperative RT is an independent predictor of improved OS and RFS. These results provide additional support for the use of RT in the multimodality treatment of retroperitoneal sarcoma. J. Surg. Oncol. 2015; 112:352–358. © 2015 Wiley Periodicals, Inc.</description><subject>Aged</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - radiotherapy</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Perioperative Care</subject><subject>Prognosis</subject><subject>radiotherapy</subject><subject>Radiotherapy, Adjuvant</subject><subject>Retroperitoneal Neoplasms - mortality</subject><subject>Retroperitoneal Neoplasms - pathology</subject><subject>Retroperitoneal Neoplasms - radiotherapy</subject><subject>Retroperitoneal Neoplasms - surgery</subject><subject>retroperitonealsarcoma</subject><subject>Retrospective Studies</subject><subject>Sarcoma - mortality</subject><subject>Sarcoma - pathology</subject><subject>Sarcoma - radiotherapy</subject><subject>Sarcoma - surgery</subject><subject>surgery</subject><subject>survival analysis</subject><subject>Survival Rate</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kTlv3DAQhQkjgb1xUvgPBATS2IVsHqJElsb6hrEucgFuCC41SriRxDVJOdl_H-5hFwHSDAec7z1g3iB0RMkpJYSdLaI_ZVypag9NKFFVoYiSb9Akz1hR1oocoHcxLgghmSn30QGrGJdMsgl6Ph9Mt4ouYt_iJQTnczHJPQMOpnG58wNOP_PfcoXdpsVxDD-cNR1OAUzqYUgbcXC9CStshgYHsGMI60GAFNaWLvkBsiSaYH1v3qO3rekifNi9h-jr1eWX6U1x_3B9Oz2_L2xZ0aoQtTSMQkmkmjfctrJtqSpB1A0jpFFC1YIIaHOtpJzPa2uN4LwBJagAwVt-iI63vsvgn0aISfcuWug6M4Afo6Y1rVTJc2gZ_fQPuvBjyOlsKKE4yZFl6mRL2eBjDNDq3d6aEr0-hs7H0JtjZPbjznGc99C8ki_pZ-BsC_x2Haz-76TvPj-8WBZbhYsJ_rwqTPilq5rXQn-fXetSzh7vLmZEf-N_AcLqpHM</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>Lane, Whitney O.</creator><creator>Cramer, Christina K.</creator><creator>Nussbaum, Daniel P.</creator><creator>Speicher, Paul J.</creator><creator>Gulack, Brian C.</creator><creator>Czito, Brian G.</creator><creator>Kirsch, David G.</creator><creator>Tyler, Douglas S.</creator><creator>Blazer III, Dan G.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20150915</creationdate><title>Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma</title><author>Lane, Whitney O. ; Cramer, Christina K. ; Nussbaum, Daniel P. ; Speicher, Paul J. ; Gulack, Brian C. ; Czito, Brian G. ; Kirsch, David G. ; Tyler, Douglas S. ; Blazer III, Dan G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4616-578a21e4089bd3cf8ff194e57d200d9597505ef750688bb7cca533de9515e53f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - radiotherapy</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Perioperative Care</topic><topic>Prognosis</topic><topic>radiotherapy</topic><topic>Radiotherapy, Adjuvant</topic><topic>Retroperitoneal Neoplasms - mortality</topic><topic>Retroperitoneal Neoplasms - pathology</topic><topic>Retroperitoneal Neoplasms - radiotherapy</topic><topic>Retroperitoneal Neoplasms - surgery</topic><topic>retroperitonealsarcoma</topic><topic>Retrospective Studies</topic><topic>Sarcoma - mortality</topic><topic>Sarcoma - pathology</topic><topic>Sarcoma - radiotherapy</topic><topic>Sarcoma - surgery</topic><topic>surgery</topic><topic>survival analysis</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lane, Whitney O.</creatorcontrib><creatorcontrib>Cramer, Christina K.</creatorcontrib><creatorcontrib>Nussbaum, Daniel P.</creatorcontrib><creatorcontrib>Speicher, Paul J.</creatorcontrib><creatorcontrib>Gulack, Brian C.</creatorcontrib><creatorcontrib>Czito, Brian G.</creatorcontrib><creatorcontrib>Kirsch, David G.</creatorcontrib><creatorcontrib>Tyler, Douglas S.</creatorcontrib><creatorcontrib>Blazer III, Dan G.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lane, Whitney O.</au><au>Cramer, Christina K.</au><au>Nussbaum, Daniel P.</au><au>Speicher, Paul J.</au><au>Gulack, Brian C.</au><au>Czito, Brian G.</au><au>Kirsch, David G.</au><au>Tyler, Douglas S.</au><au>Blazer III, Dan G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J. Surg. Oncol</addtitle><date>2015-09-15</date><risdate>2015</risdate><volume>112</volume><issue>4</issue><spage>352</spage><epage>358</epage><pages>352-358</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract>Background Radiation therapy (RT) is increasingly utilized in conjunction with surgery for the treatment of retroperitoneal soft tissue sarcomas (RPS). Despite multiple theoretical advantages of RT, its role in the surgical management of this disease remains ill defined. Methods Patients undergoing surgery for RPS from 1990 to 2011 were identified. Patients were classified as having primary or recurrent disease, and then further stratified by the use of perioperative RT. Primary outcomes, including overall survival (OS) and recurrence‐free survival (RFS), were estimated using the Kaplan‐Meier method with comparisons based on the log rank test. Cox‐proportional hazards modeling was used to estimate the independent effect of RT on survival. Results Ninety‐four patients met final inclusion criteria. After adjusting for confounding variables, perioperative RT remained independently associated with a reduced risk of recurrence (HR 0.34, P &lt; 0.01) and death (HR 0.30, P = 0.02). Conclusions In this retrospective series, perioperative RT is an independent predictor of improved OS and RFS. These results provide additional support for the use of RT in the multimodality treatment of retroperitoneal sarcoma. J. Surg. Oncol. 2015; 112:352–358. © 2015 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26238282</pmid><doi>10.1002/jso.23996</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-4790
ispartof Journal of surgical oncology, 2015-09, Vol.112 (4), p.352-358
issn 0022-4790
1096-9098
language eng
recordid cdi_proquest_miscellaneous_1716943109
source MEDLINE; Wiley Journals
subjects Aged
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Grading
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - radiotherapy
Neoplasm Recurrence, Local - surgery
Perioperative Care
Prognosis
radiotherapy
Radiotherapy, Adjuvant
Retroperitoneal Neoplasms - mortality
Retroperitoneal Neoplasms - pathology
Retroperitoneal Neoplasms - radiotherapy
Retroperitoneal Neoplasms - surgery
retroperitonealsarcoma
Retrospective Studies
Sarcoma - mortality
Sarcoma - pathology
Sarcoma - radiotherapy
Sarcoma - surgery
surgery
survival analysis
Survival Rate
title Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A28%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20perioperative%20radiation%20therapy%20in%20the%20surgical%20treatment%20of%20primary%20and%20recurrent%20retroperitoneal%20sarcoma&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Lane,%20Whitney%20O.&rft.date=2015-09-15&rft.volume=112&rft.issue=4&rft.spage=352&rft.epage=358&rft.pages=352-358&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.23996&rft_dat=%3Cproquest_cross%3E1716943109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1715930382&rft_id=info:pmid/26238282&rfr_iscdi=true